CLINICAL SUPPLY MANAGEMENT ARTICLES
How Clinical Supply Is Shaping The Next Generation Of Cell And Gene Therapies
From CAR-T to gene editing, clinical supply realities are increasingly influencing therapeutic design, scalability, and patient access.
CLINICAL SUPPLY MANAGEMENT RESOURCES
-
Learn how protocol-driven IRT systems support supply management and randomization to help trial teams cut risk and costs.
-
Biopharmaceutical drug development remains a key trend, demanding specific expertise and capabilities when it comes to quality assurance. Explore four trends that matter in biologics for clinical trial supply.
-
An inside look at a clinical-stage company focused on bringing its gene therapy from the lab into a clinical setting for patients and families devastated by rare neurological genetic diseases.
-
The pharmaceutical industry is full of acronyms. Gain insight into the evolution of the acronyms, the technology and the terminology, specifically for RTSM (Randomization and Trial Supply Management).
-
Perhaps more than any other industry, pharma and biotech have undergone radical change over the past year, as a result of the COVID-19 pandemic. From supply chain security and capacity to clinical trial operations and site auditing, almost every aspect has been affected. Experts explore how these trends are shaping the industry and offer an outlook.
-
Early collaboration with a clinical supply manager can help proactively negotiate potential pitfalls. Learn efficient resupply practices and execute successful supply chain strategies.
-
A pharma company used Signant Health's RTSM solution in a Phase 2 schizophrenia trial to ensure drug availability, maintain study balance, prevent duplicate allocations, and manage returns and destruction of unused drugs.